Randomised controlled trial to test novel invitation methods and materials targeted to increase informed uptake of lung cancer screening in individuals at high risk of lung cancer

niversity College London Biomedical Research Unit0 个研究点目标入组 1,005 人开始时间: 2015年9月23日最近更新: 2023年10月23日

适应症

试验速览

2016 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/27098676 protocol 2019 Results article in https://pubmed.ncbi.nlm.nih.gov/31558626/ cardiovascular risk results (added 27/05/2020) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33087548/ psychological burden results (added 23/10/2020) 2019 Other publications in https://pubmed.ncbi.nlm.nih.gov/31082267/ Substudy results (added 10/10/2023) 2020 Other publications in https://pubmed.ncbi.nlm.nih.gov/32164439/ Substudy results (added 10/10/2023) 2022 Other publications in https://pubmed.ncbi.nlm.nih.gov/35567604/ Substudy results (added 10/10/2023) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32759387/ nodule and cancer outcomes (added 10/10/2023)

•1. Active diagnosis of lung cancer or metastases
•2. CT thorax within the past year
•3. Inability to consent to study
•4. Palliative care register
•5. GP's alert to co-morbidity that contraindicates screening or treatment for lung cancer

发起方

niversity College London Biomedical Research Unit